Last Updated on June 22, 2023

Clinical Breast Cancer- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Elsevier

Abbreviation: Clin. Breast Cancer




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

3.01

SJR

 0.862

h-Index

 74

Rank

 5340

Important Details

Title Clinical Breast Cancer
Standard Abbreviation Clin. Breast Cancer
Type of Publication Journal
Discipline Cancer Research (Q2); Oncology (Q2)
Impact Score 3.01
SCImago Journal Rank (SJR) 0.862
h-index 74
Overall Rank 5340
Publisher Name Elsevier
Publication Country United States
International Standard Serial Number (ISSN) 15268209, 19380666
Coverage and History 2000-2022
Best Quartile Q2
Total Citations Received
(Last 3 Year)
1348

About Clinical Breast Cancer


Clinical Breast Cancer is a journal published by Elsevier. This journal covers the area[s] related to Cancer Research, Oncology, etc. The coverage history of this journal is as follows: 2000-2022. The rank of this journal is 5340. This journal's impact score, h-index, and SJR are 3.01, 74, and 0.862, respectively. The ISSN of this journal is/are as follows: 15268209, 19380666.

The best quartile of Clinical Breast Cancer is Q2. This journal has received a total of 1348 citations during the last three years (Preceding 2022).


Clinical Breast Cancer Impact Score 2022-2023


The latest impact score (IS) of the Clinical Breast Cancer is 3.01. It is computed in the year 2023 as per its definition and based on Scopus data. 3.01

It is increased by a factor of around 0.21, and the percentage change is 7.5% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Clinical Breast Cancer Impact Score 2023


Impact Score 2022 of Clinical Breast Cancer is 3.01. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Clinical Breast Cancer. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 3.01
2021 2.80
2020 2.94
2019 2.52
2018 2.38
2017 2.61
2016 2.42
2015 3.07
2014 2.52

Clinical Breast Cancer h-index


  Table Setting

The h-index of Clinical Breast Cancer is 74. By definition of the h-index, this journal has at least 74 published articles with more than 74 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Clinical Breast Cancer ISSN


The International Standard Serial Number (ISSN) of Clinical Breast Cancer is/are as follows: 15268209, 19380666.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Clinical Breast Cancer Ranking and SCImago Journal Rank (SJR)


The Clinical Breast Cancer is ranked 5340 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.862.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Clinical Breast Cancer Publisher


Table Setting

The publisher of Clinical Breast Cancer is Elsevier. The publishing house of this journal is located in the United States. Its coverage history is as follows: 2000-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Clinical Breast Cancer is Clin. Breast Cancer. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Clin. Breast Cancer') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Clinical Breast Cancer


If your area of research or discipline is related to Cancer Research, Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Clinical Breast Cancer?

The latest impact score of Clinical Breast Cancer is 3.01. It is computed in the year 2023.


What is the h-index of Clinical Breast Cancer?

The latest h-index of Clinical Breast Cancer is 74. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Clinical Breast Cancer?

The latest SCImago Journal Rank (SJR) of Clinical Breast Cancer is 0.862. It is calculated in the year 2023.


What is the ranking of Clinical Breast Cancer?

The latest ranking of Clinical Breast Cancer is 5340. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Clinical Breast Cancer?

Clinical Breast Cancer is published by Elsevier. The publication country of this journal is United States.


What is the abbreviation of Clinical Breast Cancer?

This standard abbreviation of Clinical Breast Cancer is Clin. Breast Cancer.


Is "Clinical Breast Cancer" a Journal, Conference or Book Series?

Clinical Breast Cancer is a journal published by Elsevier.


What is the scope of Clinical Breast Cancer?

The scope of Clinical Breast Cancer is as follows:

  • Cancer Research
  • Oncology

For detailed scope of Clinical Breast Cancer, check the official website of this journal.


What is the ISSN of Clinical Breast Cancer?

The International Standard Serial Number (ISSN) of Clinical Breast Cancer is/are as follows: 15268209, 19380666.


What is the best quartile for Clinical Breast Cancer?

The best quartile for Clinical Breast Cancer is Q2.


What is the coverage history of Clinical Breast Cancer?

The coverage history of Clinical Breast Cancer is as follows 2000-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Journal of Academic Ethics Journal Springer Netherlands 8920 26 2.28
Revue Francophone des Laboratoires (discontinued) Journal Elsevier Masson s.r.l. 23244 8 0.00
Materials Research Journal Universidade Federal de Sao Carlos 14791 65 1.62
Mathematical Modelling and Analysis Journal Vilnius Gediminas Technical University 11315 27 1.75
International Journal of Parallel, Emergent and Distributed Systems Journal Taylor and Francis Ltd. 15843 23 1.28
European Journal of Education Journal Wiley-Blackwell Publishing Ltd 6079 53 2.31
Indian Phytopathology Journal Springer Nature 14222 11 1.33
Biological Procedures Online Journal BioMed Central Ltd. 3350 43 6.40
Genes and Nutrition Journal BioMed Central Ltd. 6154 61 3.28
Proceedings of the Royal Society of Queensland Journal Royal Society of Queensland 22998 12 0.48

Check complete list




Clinical Breast Cancer Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 3.01
2021 2.80
2020 2.94
2019 2.52
2018 2.38
2017 2.61
2016 2.42
2015 3.07
2014 2.52



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All